Pharmaceutical Research, 2011: PhRMA's 2011 industry profile reports 2010 research and development spending of $49.4 billion by member companies and $67.4 billion for the total industry, with 2009 at $46.4 billion and $65.9 billion respectively.
2010 $49.4 billion (est.) $67.4 billion (est.)
R&D Spending table
Pharmaceutical Research, 2011: PhRMA's 2011 industry profile reports 2010 research and development spending of $49.4 billion by member companies and $67.4 billion for the total industry, with 2009 at $46.4 billion and $65.9 billion respectively. Issuer is the industry's own trade association, so the figure is self-reported; the copy read is KEI's mirror of PhRMA's PDF, and phrma.org is the original host. No drug or comparator. The $67.4B R&D figure is more than ten times the '$6 billion' promotional figure in the claim, which makes the 'more than they spent on actual research' half false whichever 2010 promotional estimate is used (see CHE-28). Study type: other.
